drugset / Trial / NCT02273466

Pharmacokinetics of Oral Desipramine With and Without Concomitant Administration of Crobenetine Infusion in Healthy Male Subjects

NCT02273466

Phase 1 Completed 24 enrolled Boehringer Ingelheim
RandomizedCrossoverSingle-blindTreatment

Summary

To assess the steady state pharmacokinetics of Desipramine with/without concomitant administration of Crobenetine.

Timeline

Start
2002-02
Primary completion
2002-04
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Crobenetine Small molecule 175 mg Intravenous
Subject Desipramine Small molecule 50 mg Oral

Indications

No indication recorded.